globalincomeexperts.com
  • Investing News
  • Stock News
  • World News
  • Business News
Stock News

Lithium Americas shares surge 60% as Trump reportedly eyes US stake

by admin September 24, 2025
September 24, 2025

Shares of Lithium Americas surged by almost 60% in premarket trading on Wednesday after a Reuters report that the Trump administration is seeking an equity stake of up to 10% in the Canadian miner.

The stake would be tied to renegotiations of a $2.26 billion US Energy Department loan for the company’s Thacker Pass lithium project in Nevada, a venture with General Motors.

The potential deal marks the latest intervention by Washington in sectors deemed vital to national security.

The administration has recently sought equity positions in Intel, MP Materials and other firms to secure domestic production capacity in technology and minerals.

A White House official told Reuters that the president wanted the project to succeed while safeguarding taxpayers’ interests.

“President Trump supports this project. He wants it to succeed and also be fair to taxpayers,” the official said. “But there’s no such thing as free money.”

Thacker Pass seen as linchpin of US supply chain

The Thacker Pass mine, under construction for nearly a year with more than 600 contractors on site, is slated to open in 2028.

Located about 25 miles south of Nevada’s border with Oregon, it is expected to become the largest lithium source in the Western Hemisphere.

Lithium is a crucial component in batteries for electric vehicles and electronics.

The project is central to US efforts to build a domestic supply chain and reduce reliance on China, which dominates lithium refining and processes over 75% of global supply.

Phase one of Thacker Pass is projected to produce 40,000 metric tons of battery-quality lithium carbonate annually, enough for up to 800,000 electric vehicles.

The scale could surpass the regional output of industry leader Albemarle, which currently operates the only US lithium mine.

Analysts say equity stake an indicator of favourable ROIC

Shares of Lithium Americas jumped from around $3 to $5.54 following the news, with analysts suggesting equity stakes could signal stronger government support.

“Markets can view equity stakes as a leading indicator of favorable ROIC (return on invested capital)… the incentive for taking equity stakes seem significantly higher than withdrawing funding,” said analysts at Jefferies.

General Motors, which owns 38% of the Thacker Pass project, saw its shares rise 2.9% before the opening bell.

Other lithium producers also benefited, with Albemarle up 5.2%, Sigma Lithium gaining 5.3% and SQM climbing 2.7% in light trading.

The project’s estimated $2.93 billion cost was first approved at the end of Trump’s previous term.

While the Department of Energy’s Loan Programs Office closed the loan under the Biden administration, current talks reflect Trump’s strategy of tying state support to direct equity stakes in critical projects.

Global race for lithium intensifies

China remains a dominant force in the global lithium market, producing more than 40,000 metric tons annually and refining the majority of global supply into battery-grade material.

Australia and Chile lead global mining output, but Washington views the Thacker Pass project as crucial to diversifying supply and strengthening energy security.

The US currently produces less than 5,000 metric tons annually, highlighting the potential impact of the Nevada mine.

Analysts say US involvement through equity stakes could accelerate investment and provide stability in a sector where supply security is increasingly tied to geopolitical strategy.

While Lithium Americas reported a widening net loss in the second quarter, the latest development suggests government backing could alter the company’s outlook and cement its role in America’s critical minerals future.

The post Lithium Americas shares surge 60% as Trump reportedly eyes US stake appeared first on Invezz

previous post
Here’s why the crypto market is crashing this week
next post
Eli Lilly CEO slams UK drug pricing: what’s behind the backlash?

You may also like

Why Tesla’s record Q3 is a one-time high,...

October 3, 2025

USA Rare Earth shares jump after CEO confirms...

October 3, 2025

Huawei’s AI chips rely on foreign parts despite...

October 3, 2025

Dow futures soar over 100 points today: 5...

October 3, 2025

FTSE 100 hits record high as financial stocks...

October 3, 2025

Europe markets open: Stoxx 600 jumps 0.6%, led...

October 2, 2025

Will the Tesco share price hit 500p as...

October 2, 2025

Tesco lifts profit forecast as summer, price cuts,...

October 2, 2025

Chinese carmakers expand hybrid sales in Europe as...

October 2, 2025

Hackers exploit Oracle systems, executives hit with ransom...

October 2, 2025






    Become a VIP member by signing up for our newsletter. Enjoy exclusive content, early access to sales, and special offers just for you! As a VIP, you'll receive personalized updates, loyalty rewards, and invitations to private events. Elevate your experience and join our exclusive community today!


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Recent Posts

    • FLASHBACK: James Comey urged officials to always prosecute high-profile perjury cases
    • Trump’s DOGE savings dwarfed by Medicare, Social Security spending, watchdog finds
    • Reagan-appointed judge, once rebuked by Supreme Court, continues to lambaste Trump
    • Hawley blasts FDA approval of new abortion drug, cites safety and trust concerns
    • Federal judge to sentence Justice Brett Kavanaugh’s attempted assassin
    • About us
    • Privacy Policy
    • Terms & Conditions

    Copyright © 2025 globalincomeexperts.com | All Rights Reserved

    globalincomeexperts.com
    • Investing News
    • Stock News
    • World News
    • Business News